AMY THOMPSON: Open Payments
NPI 1447003736 · LOUISVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$500 in 11 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $500
Food & beverage: $500
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 1 | $139 |
| Genmab U.S., Inc. | 3 | $138 |
| GENZYME CORPORATION | 1 | $101 |
| AstraZeneca Pharmaceuticals LP | 2 | $37 |
| Incyte Corporation | 2 | $36 |
| Verastem, Inc. | 1 | $30 |
| Genentech USA, Inc. | 1 | $19 |
Products named: TALVEY, Tivdak, WAYRILZ, AVMAPKI FAKZYNJA CO-PACK, ZYNYZ, Polivy, NIKTIMVO, TAGRISSO.
Industry payments across KY — which companies pay providers there.
